NCT04602481

Brief Summary

Living with PCD (formerly COVID-PCD) is a participatory research project that aims to answer emerging questions about primary ciliary dyskinesia (PCD) in order to improve the health and quality of life of people with PCD. Persons with confirmed or suspected PCD from anywhere in the world can participate. The study is advertised through patient support groups and participants register online after they read detailed information about the study. Participants receive a detailed questionnaire when they start the study and a follow-up questionnaire (planned once per year). Occasionally, participants receive extra questionnaires focused on special topics. The study is hosted at the University of Bern and recruitment started on May 30th, 2020.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
50mo left

Started May 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
May 2020May 2030

Study Start

First participant enrolled

May 31, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 26, 2020

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2030

Last Updated

December 2, 2025

Status Verified

November 1, 2025

Enrollment Period

10 years

First QC Date

October 23, 2020

Last Update Submit

November 26, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Patient-reported respiratory symptoms

    Prevalence of reported clinical symptoms at different age groups such as cough, shortness of breath, hearing problems

    At baseline and through study completion, an average of 1 year

  • Exercise-behaviour

    Characteristics of exercise-behaviours (frequency, type) at baseline

    At baseline and through study completion, an average of 1 year

  • Treatments

    Information about prescribed treatments for PCD including antibiotics, inhalations, and physiotherapy

    At baseline and through study completion, an average of 1 year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study includes all persons with primary ciliary dyskinesia who can be contacted via patient organisation networks worldwide.

You may qualify if:

  • People of any age with reported suspected or confirmed Primary Ciliary Dyskinesia who gave consent to participate in the study

You may not qualify if:

  • People who report not to have suspected or confirmed Primary Ciliary Dyskinesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Social and Preventive Medicine (ISPM), University of Bern

Bern, 3012, Switzerland

RECRUITING

Related Publications (1)

  • Schreck LD, Pedersen ESL, Dexter K, Manion M; Living with PCD Study Advisory Group; Massin N, Maitre B, Goutaki M, Kuehni CE. Infertility and pregnancy outcomes among adults with primary ciliary dyskinesia. Hum Reprod Open. 2024 Jun 18;2024(3):hoae039. doi: 10.1093/hropen/hoae039. eCollection 2024.

Related Links

MeSH Terms

Conditions

Ciliary Motility Disorders

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesCiliopathiesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Study Officials

  • Claudia E Kuehni, Prof.

    University of Bern

    PRINCIPAL INVESTIGATOR
  • Myrofora Goutaki, Prof

    University of Bern

    STUDY DIRECTOR

Central Study Contacts

Claudia E Kuehni, Prof.

CONTACT

Myrofora Goutaki, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2020

First Posted

October 26, 2020

Study Start

May 31, 2020

Primary Completion (Estimated)

May 31, 2030

Study Completion (Estimated)

May 31, 2030

Last Updated

December 2, 2025

Record last verified: 2025-11

Locations